Rice Hall James & Associates LLC boosted its position in Maximus, Inc. (NYSE:MMS – Free Report) by 4.2% during the 1st quarter, Holdings Channel.com reports. The fund owned 222,924 shares of the health services provider’s stock after buying an additional 8,929 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Maximus were worth $14,289,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Maximus in the 1st quarter valued at about $4,177,000. Capula Management Ltd bought a new stake in shares of Maximus during the first quarter worth approximately $422,000. Bank of Nova Scotia raised its stake in shares of Maximus by 20.9% during the first quarter. Bank of Nova Scotia now owns 5,088 shares of the health services provider’s stock worth $326,000 after buying an additional 879 shares during the last quarter. Sei Investments Co. lifted its holdings in Maximus by 12.7% in the first quarter. Sei Investments Co. now owns 93,826 shares of the health services provider’s stock valued at $6,014,000 after buying an additional 10,574 shares during the period. Finally, Walleye Capital LLC lifted its holdings in Maximus by 115.7% in the first quarter. Walleye Capital LLC now owns 428,618 shares of the health services provider’s stock valued at $27,474,000 after buying an additional 229,879 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Maximus Stock Performance
Shares of MMS stock opened at $59.60 on Friday. The stock has a market cap of $3.13 billion, a PE ratio of 8.92 and a beta of 0.60. The stock has a 50-day moving average of $58.57 and a 200-day moving average of $69.80. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.21 and a quick ratio of 2.21. Maximus, Inc. has a one year low of $52.73 and a one year high of $100.00.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, August 14th. Maximus’s dividend payout ratio (DPR) is currently 19.76%.
Wall Street Analyst Weigh In
A number of research firms have commented on MMS. Weiss Ratings lowered shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Read More
- Five stocks we like better than Maximus
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
